Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 754 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR After a Breast Cancer Diagnosis, Men May Be More Likely to... October 2, 2019 Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to... December 9, 2022 Enhertu May Be Preferred Therapy for Some Metastatic Breast Cancers October 19, 2021 This Amazing Woman Can Smell Alzheimer’s, Parkinson’s, and Cancer Years Before... March 22, 2019 Load more HOT NEWS Characterisation of KRAS, Including KRAS G12C, Mutations in Gastrointestinal and Metastatic... Five Questions With…Jae. Cancer in My Community: The 3 Ways People Access Cancer Care... Time to take on 9 new Cancer Grand Challenges
